FCGR2A and mastocytoma: Then, PD-1+ CB-NKs were assessed for degranulation capability in a reverse antibody-dependent cellular cytotoxicity (R-ADCC) against the murine FcγR+ P815 mastocytoma cell line (PD-L1/PD-L2 negative).